PMID- 36180273 OWN - NLM STAT- MEDLINE DCOM- 20221004 LR - 20231001 IS - 1559-4106 (Electronic) IS - 1934-8630 (Print) IS - 1559-4106 (Linking) VI - 17 IP - 5 DP - 2022 Sep 30 TI - Interleukin 1beta and lipopolysaccharides induction dictate chondrocyte morphological properties and reduce cellular roughness and adhesion energy comparatively. PG - 051001 LID - 10.1116/6.0001986 [doi] LID - 051001 AB - Osteoarthritis (OA) is a whole joint disease marked by the degradation of the articular cartilage (AC) tissue, chronic inflammation, and bone remodeling. Upon AC's injury, proinflammatory mediators including interleukin 1beta (IL1beta) and lipopolysaccharides (LPS) play major roles in the onset and progression of OA. The objective of this study was to mechanistically detect and compare the effects of IL1beta and LPS, separately, on the morphological and nanomechanical properties of bovine chondrocytes. Cells were seeded overnight in a full serum medium and the next day divided into three main groups: A negative control (NC) of a reduced serum medium and 10 ng/ml IL1ss or 10 ng/ml LPS-modified media. Cells were induced for 24 h. Nanomechanical properties (elastic modulus and adhesion energy) and roughness were quantified using atomic force microscopy. Nitric oxide, prostaglandin 2 (PGE2), and matrix metalloproteinases 3 (MMP3) contents; viability of cells; and extracellular matrix components were quantified. Our data revealed that viability of the cells was not affected by inflammatory induction and IL1ss induction increased PGE2. Elastic moduli of cells were similar among IL1beta and NC while LPS significantly decreased the elasticity compared to NC. IL1ss induction resulted in least cellular roughness while LPS induction resulted in least adhesion energy compared to NC. Our images suggest that IL1ss and LPS inflammation affect cellular morphology with cytoskeleton rearrangements and the presence of stress fibers. Finally, our results suggest that the two investigated inflammatory mediators modulated chondrocytes' immediate responses to inflammation in variable ways. FAU - Mallah, Alia H AU - Mallah AH AUID- ORCID: 0000-0001-9555-5583 AD - Department of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio (UTSA), San Antonio, Texas 78249. FAU - Amr, Mahmoud AU - Amr M AUID- ORCID: 0000-0002-8555-8497 AD - Department of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio (UTSA), San Antonio, Texas 78249. FAU - Gozen, Arda AU - Gozen A AUID- ORCID: 0000-0002-2680-2269 AD - School of Mechanical and Materials Engineering, Washington State University, Pullman, Washington 99164. FAU - Mendenhall, Juana AU - Mendenhall J AD - Department of Chemistry, Morehouse College, Atlanta, Georgia 30314. FAU - Van-Wie, Bernard J AU - Van-Wie BJ AUID- ORCID: 0000-0001-7382-9715 AD - Gene and Linda Voiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, Washington 99164. FAU - Abu-Lail, Nehal I AU - Abu-Lail NI AUID- ORCID: 0000-0002-2319-2450 AD - Department of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio (UTSA), San Antonio, Texas 78249. LA - eng GR - T32 GM008336/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20220930 PL - United States TA - Biointerphases JT - Biointerphases JID - 101275679 RN - 0 (Interleukin-1beta) RN - 0 (Lipopolysaccharides) RN - 31C4KY9ESH (Nitric Oxide) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - K7Q1JQR04M (Dinoprostone) SB - IM MH - Animals MH - Cattle MH - Cells, Cultured MH - *Chondrocytes/metabolism MH - Dinoprostone/metabolism/pharmacology MH - Inflammation MH - Interleukin-1beta/metabolism/pharmacology MH - Lipopolysaccharides/toxicity MH - Matrix Metalloproteinase 3/metabolism/pharmacology MH - Nitric Oxide/pharmacology MH - *Osteoarthritis/metabolism PMC - PMC9526521 EDAT- 2022/10/01 06:00 MHDA- 2022/10/05 06:00 PMCR- 2023/09/30 CRDT- 2022/09/30 22:03 PHST- 2022/09/30 22:03 [entrez] PHST- 2022/10/01 06:00 [pubmed] PHST- 2022/10/05 06:00 [medline] PHST- 2023/09/30 00:00 [pmc-release] AID - 6.0001986 [pii] AID - 10.1116/6.0001986 [doi] PST - epublish SO - Biointerphases. 2022 Sep 30;17(5):051001. doi: 10.1116/6.0001986.